Hefner, Gudrun; Hahn, Martina; Hiemke, Christoph et al.
Pharmacodynamic Drug-Drug interactions of QT-prolonging drugs in hospitalized psychiatric patientsJOURNAL OF NEURAL TRANSMISSION. Bd. 128. H. 2. 2021 S. 243-252
Schoretsanitis, Georgios; Haen, Ekkehard; Piacentino, Daria et al.
Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug ReactionsCLINICAL PHARMACOKINETICS. Bd. 60. H. 12. 2021 S. 1583-1589
Appel, Dominik; Hummel, Regina; Weidemeier, Martin et al.
Pharmacologic Inhibition of ADAM10 Attenuates Brain Tissue Loss, Axonal Injury and Pro-inflammatory Gene Expression Following Traumatic Brain Injury in MiceFRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. Bd. 9. 2021
Chmitorz, A; Ottenhausen, M; Kalasauskas, D et al.
Pharmacological Neuroenhancement, Perceived Stress, and Resilience in Spine Surgeons-A Cross-Sectional SurveyWorld Neurosurg. Bd. S1878-8750. H. 21. 2021 S. 01672-7
Rösler, M; Retz, W; Turner, D
Pharmacotherapy of ADHD in Adults.Riederer P, Laux G, Nagatsu T, Le W, Riederer C (Hrsg). NeuroPsychopharmacotherapy. Springer Nature Switzerland 2021
Wolff, Jan; Reissner, Pamela; Hefner, Gudrun et al.
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disordersPLOS ONE. Bd. 16. H. 7. 2021
Hahad, Omar; Kuntic, Marin; Frenis, Katie et al.
Physical Activity in Polluted Air-Net Benefit or Harm to Cardiovascular Health? A Comprehensive ReviewANTIOXIDANTS. Bd. 10. H. 11. 2021
Wolff, Jan; Hefner, Gudrun; Normann, Claus et al.
Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatryPHARMACOEPIDEMIOLOGY AND DRUG SAFETY. Bd. 30. H. 9. 2021 S. 1258-1268
Wolff, Jan; Hefner, Gudrun; Normann, Claus et al.
Predicting the risk of drug-drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance studyBMJ OPEN. Bd. 11. H. 4. 2021
Pfeifer, Philippe; Sebastian, Alexandra; Buchholz, Hans Georg et al.
Prefrontal and striatal dopamine D-2/D-3 receptors correlate with fMRI BOLD activation during stoppingBRAIN IMAGING AND BEHAVIOR. Bd. 16. H. 1. 2021 S. 186-198